The rationale of prevention of thrombosis by enhancing blood levels of single-chain urokinase-type plasminogen activator (scuPA).
Dooijewaard
G
G
Gaubius Laboratory, IVVO-TNO, Leiden, The Netherlands.
van Boheemen
P A
PA
Binnema
D J
DJ
Kluft
C
C
D002318:Cardiovascular Diseases / Q000150:complications / Q000503:physiopathology; D005342:Fibrinolysis; D006801:Humans; D008954:Models, Biological; D008955:Models, Cardiovascular; D013927:Thrombosis / Q000517:prevention & control*; D010959:Tissue Plasminogen Activator / Q000097:blood; D014568:Urokinase-Type Plasminogen Activator / Q000097:blood*
D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator